Psychiatry & Neurology, Psychosomatic Medicine · Manhasset, NY
NPI
1346468600
Since 2007
Specialty
Psychiatry & Neurology, Psychosomatic Medicine
Code 2084P0015X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1165 Northern Blvd., Suite 200
Manhasset, NY, 11030
Phone (516) 365-3300
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$870K
4,588 prescriptions
Company payments, 2025
$68K
From 7 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jeremy D Coplan prescribed most often to Medicare patients was Lamotrigine, with 598 prescriptions and refills. In total Jeremy D Coplan wrote 4,588 Medicare prescriptions that cost $870K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Lamotrigine Generic | 598 | 978 | 86 | $7,806 |
| Clonazepam Generic | 253 | 278 | 43 | $3,674 |
| Quetiapine Fumarate Generic | 223 | 315 | 37 | $4,746 |
| Bupropion Xl Bupropion Hcl | 205 | 375 | 36 | $5,217 |
| Escitalopram Oxalate Generic | 205 | 322 | 34 | $2,243 |
| Aripiprazole Generic | 152 | 248 | 32 | $18K |
| Alprazolam Generic | 145 | 155 | 33 | $1,434 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 137 | 161 | 20 | $5,038 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 129 | 209 | 17 | $2,060 |
| Lurasidone Hcl Generic | 124 | 138 | 14 | $23K |
| Trazodone Hcl Generic | 123 | 179 | 30 | $1,146 |
| Vyvanse Lisdexamfetamine Dimesylate | 105 | 105 | 14 | $45K |
| Lorazepam Generic | 96 | 98 | 18 | $850 |
| Sertraline Hcl Generic | 93 | 165 | 18 | $879 |
| Vraylar Cariprazine Hcl | 92 | 92 | 13 | $126K |
Brand drugs: - claims; generic drugs: 4,054 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeremy D Coplan $68K ($68K in general payments such as food, travel and fees) from 7 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $43K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.